Cytotoxicity of RNases is increased by cationization and counteracted by KCa channels

Biochemical and Biophysical Research Communications

Volumn 314, Issue 2, 2004, Pages 550-554

  Ilinskaya, Olga N ^a,b   Koschinski, Andreas ^c   Mitkevich, Vladimir A ^a,d   Repp, Holger ^c   Dreyer, Florian ^c   Pace, C Nick ^e   Makarov, Alexander A ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^c JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^d UNIVERSITY OF OSLO   (Norway)

^e TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Charge reversal mutants; Cytotoxicity; Human embryonic kidney cells; KCa channels; Ribonuclease Sa

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; MEMBRANE PROTEIN; RANPIRNASE; RIBONUCLEASE;

ARTICLE; CATALYSIS; CELL PROTECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DATA ANALYSIS; EMBRYO; ENZYME ACTIVITY; ENZYME STABILITY; HUMAN; HUMAN CELL; IONIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOMYCES AUREOFACIENS;

STREPTOMYCES; STREPTOMYCES AUREOFACIENS;

EID: 0347635412     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.110     Document Type: Article

References (30)

1. Kourie J.I. Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity. Chem. Biol. Interact. 138:2001;1-26.
2. Kourie J.I. Mechanisms of amyloid beta protein-induced modification in ion transport systems: implications for neurodegenerative diseases. Cell. Mol. Neurobiol. 21:2001;173-213.
3. Chi X., Sutton E.T., Hellermann G., Prince J.M. Potassium channel openers prevent beta-amyloid toxicity in bovine vascular endothelial cells. Neurosci. Lett. 290:2000;9-12.
4. + channel of intermediate conductance: a molecular target for novel treatments? Curr. Drug Targets. 2:2001;401-422.
5. + channel of intermediate conductance: a possible target for immune suppression. Expert Opin. Ther. Targets. 6:2002;623-636.
6. Shen A.Y., Wu S.N., Chiu C.T. Synthesis and cytotoxicity evaluation of some 8-hydroxyquinoline derivatives. J. Pharm. Pharmacol. 51:1999;543-548.
7. + channel. Am. J. Physiol. 275:1998;848-856.
8. 2+ current. Biochem. Biophys. Acta. 1269:1995;57-63.
9. Ilinskaya O., Decker K., Koschinski A., Dreyer F., Repp H. Bacillus intermedius ribonuclease as inhibitor of cell proliferation and membrane current. Toxicology. 156:2001;101-107.
10. Ilinskaya O.N., Dreyer F., Mitkevich V.A., Shaw K.L., Pace C.N., Makarov A.A. Changing the net charge from negative to positive makes ribonuclease Sa cytotoxic. Protein Sci. 11:2002;2522-2525.
11. Sevcik J., Urbanikova L., Leland P.A., Raines R.T. X-ray structure of two crystalline forms of a Streptomycete ribonuclease with cytotoxic activity. J. Biol. Chem. 277:2003;47325-47330.
12. Laurents D.V., Huyghues-Despointes B.M., Bruix M., Thurlkill R.L., Schell D., Newsom S., Grimsley G.R., Shaw K.L., Trevino S., Rico M., Briggs J.M., Antosiewicz J.M., Scholtz J.M., Pace C.N. Charge-charge interactions are key determinants of the pK values of ionizable groups in ribonuclease Sa (p. I =3.5) and a basic variant (p I =10.2) J. Mol. Biol. 325:2003;1077-1092.
13. Pace C.N., Hebert E.J., Shaw K.L., Schell D., Both V., Krajcikova D., Sevcik J., Wilson K.S., Dauter Z., Hartley R., Grimsley G.R. Conformational stability and thermodynamics of folding of ribonucleases Sa, Sa2 and Sa3. J. Mol. Biol. 279:1998;271-286.
14. Shaw K.L., Grimsley G.R., Yakovlev G.I., Makarov A.A., Pace C.N. The effect of net charge on the solubility, activity, and stability of ribonuclease Sa. Protein Sci. 10:2001;1206-1215.
15. Yakovlev G.I., Mitkevich V.A., Shaw K.L., Trevino S., Newsom S., Pace C.N., Makarov A.A. Contribution of active site residues to the activity and thermal stability of ribonuclease Sa. Protein Sci. 12:2003;2367-2373.
16. Hebert E.J., Grimsley G.R., Hartley R.W., Horn G., Schell D., Garcia S., Both V., Sevcik J., Pace C.N. Purification of ribonucleases Sa, Sa2, and Sa3 after expression in Escherichia coli. Protein Expr. Purif. 11:1997;162-168.
17. Joiner W.J., Wang L.Y., Tang M.D., Kaczmarek L.K. hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc. Natl. Acad. Sci. USA. 94:1997;11013-11018.
18. + current in mouse fibroblasts by lysophosphatidic acid requires a pertussis toxin-sensitive G protein and Ras. Naunyn Schmiedebergs Arch. Pharmacol. 358:1998;509-517.
19. + current in mouse fibroblasts by sphingosine-1-phosphate involves the protein tyrosine kinase c-Src. Naunyn Schmiedebergs Arch. Pharmacol. 363:2001;295-301.
20. 2+ oscillations. Cell. Microbiol. 4:2002;483-491.
21. Makarov A.A., Ilinskaya O.N. Cytotoxic ribonucleases: molecular weapons and their targets. FEBS Lett. 540:2003;15-20.
22. Klink T.A., Raines R.T. Conformational stability is a determinant of ribonuclease A cytotoxicity. J. Biol. Chem. 275:2000;17463-17467.
23. Futami J., Maeda T., Kitazoe M., Nukui E., Tada H., Seno M., Kosaka M., Yamada H. Preparation of potent cytotoxic ribonucleases by cationization: enhanced cellular uptake and decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl groups. Biochemistry. 40:2001;7518-7524.
24. Ogawa Y., Iwama M., Ohgi K., Tsuji T., Irie M., Itagaki T., Kobayashi H., Inokuchi N. Effect of replacing the aspartic acid/glutamic acid residues of bullfrog sialic acid binding lectin with asparagines/glutamine and arginine on the inhibition of cell proliferation in murine leukemia P388 cells. Biol. Pharm. Bull. 25:2002;722-727.
25. Ran S., Downes A., Thorpe P.E. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 62:2002;6132-6140.
26. + current by the oncogenic receptor protein tyrosine kinase v-Fms in mouse fibroblasts. Naunyn Schmiedebergs Arch. Pharmacol. 357:1998;378-384.
27. Ilinskaya O.N., Vamvakas S. Nephrotoxic effects of bacterial ribonucleases in the isolated perfused rat kidney. Toxicology. 120:1997;55-63.
28. Vasandani V.M., Wu Y.-N., Mikulski S.M., Youle R.J., Sung C. Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamily. Cancer Res. 56:1996;4180-4186.
29. Bracale A., Spalletti-Cernia D., Mastronicola M., Castaldi F., Mannucci R., Nitsch L., D'Alessio G. Essential stations in the intracellular pathway of cytotoxic bovine seminal ribonuclease. Biochem. J. 362:2002;553-560.
30. Matousek J., Gotte G., Pouckova P., Soucek J., Slavik T., Vottariello F., Libonati M. Antitumor activity and other biological actions of oligomers of ribonuclease A. J. Biol. Chem. 278:2003;23817-23822.